Lifespan extension therapy: Tetrahydrocannabinolic acid [THCA], found abundantly in Hemp Cannabis Sativa, among others,  may increase life span via up-regulation of its target gene BubR1, 25/October/2017, 12.38 am

Molecular therapy for body weight control, energy homeostasis and TIIDM:  Chenodeoxycholic acid (CDCA) [Trade name: Ursodiol] decreases CADM1 and its downstream target genes that promote glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 25/October/2017, 12.01 am
October 24, 2017
Natural product therapy for Diabetic nephropathy (DN):  Yangonin, isolated from Kava Kava, among others, increases Pyruvate kinase M2 (PKM2) expression, decreases toxic glucose metabolites, mitochondrial dysfunction and apoptosis, augments glycolytic flux and PGC-1α levels, improves metabolic abnormalities, albuminuria, glomerular pathology, and renal dysfunction and alleviates diabetic nephropathy via down regulation of its target gene, 25/October/2017, 1.04 am
October 24, 2017
Show all

 What they say: Introduction: 

A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School of Medicine, The University of New South Wales, Australia shows that Sirtuin-2 induces the checkpoint kinase BubR1 to increase lifespan. This study was published, in the 1 July  2014 issue of the journal  “EMBO”, by Prof Sinclair, North BJ, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Lifespan extension therapy: Tetrahydrocannabinolic acid [THCA], found abundantly in Hemp Cannabis Sativa, among others,  may increase life span via up-regulation of its target gene BubR1


What is known? 

Tetrahydrocannabinolic acid [THCA] has been shown to possess neuroprotective activity. However, the exact mechanism of action is far from clear.


From Research Findings to Therapeutic Opportunity: 

This study suggests, for the first time, that Tetrahydrocannabinolic acid [THCA]by increasing the expression of its target gene, it may: (a) increase the expression of BuBR1; (b) decrease the expression of p70 S6 Kinase; and (c) regulate the expression of a number of longevity-promoting molecules (Fig. 1).

[easy_payment currency=”USD”]

Figure 1. A therapeutic mix encompassing  Tetrahydrocannabinolic acid [THCA]  may extend  mammalian life span via up regulation of BuBR1 and down regulation of p70 S6 Kinase

Thereby, it may: (1) increase insulin sensitivity; (2) increase thermogenesis, lipolysis and oxidative metabolism; (3) inhibit obesity; (4) attenuate cognitive impairment; (5) delay diseases of aging; (6) slow down cardiac aging; (7) promote resistance to bone, immune and motor dysfunction; (8) promote tissue rejuvenation; and (9) prolong median life span. Thus, pharmacological formulations encompassing “Tetrahydrocannabinolic acid [THCA]  or its analogues, either alone or in combination with other drugs” may be used to extend the lifespan of an individual (fig. 1).


Details on the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Amount: $500#

Undisclosed mechanistic information: How a pharmaceutical mix encompassing Tetrahydrocannabinolic acid [THCA] increases the expression of BubR1 and extends mammalian life-span

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

# Research cooperation


References

Web: http://genomediscovery.org or http://newbioideas.com

CitationBoominathan, L., Lifespan extension therapy: Tetrahydrocannabinolic acid [THCA], found abundantly in Hemp Cannabis Sativa, among others,  may increase life span via up-regulation of its target gene BubR1, 25/October/2017, 12.38 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at admin@genomediscovery.org

Comments are closed.